Strand Therapeutics develops programmable, long-acting mRNA therapeutics that utilize logic-based circuits to target and activate treatments specifically in diseased cells. This technology addresses the challenge of delivering precise, multi-functional therapies while minimizing off-target effects, aiming to improve treatment outcomes for cancer and other life-threatening diseases.
Funding
$102.6M raised to dateRaised to date based on public sources. This may differ from the amount the company actually raised and is based only on what is publicly available on the internet.
Founders
Product
Problem
Current mRNA therapies lack precise control over where and when they are active, leading to potential off-target effects and limiting their therapeutic window. This lack of specificity can result in toxicity and reduced efficacy, especially when treating diseases like cancer that require targeted intervention.
Solution
Strand Therapeutics is developing a platform for programmable mRNA therapeutics that uses synthetic biology to control the location, timing, intensity, and duration of protein expression. By incorporating logic-based circuits into mRNA, the therapeutics can sense different cell types and only activate in diseased cells. This approach increases the therapeutic window by allowing the mRNA to travel throughout the body while ensuring its therapeutic protein payload acts only in the appropriate locations, turning off in healthy cells. Strand's self-replicating mRNAs aim to provide improved treatment options for cancer and other life-threatening diseases.
Target Audience
The primary target audience includes patients with cancer and other life-threatening diseases, as well as pharmaceutical companies seeking to develop more targeted and effective mRNA therapies.
Features
- Programmable mRNA therapeutics with logic-based circuits for precise control of protein expression
- Ability to sense different cell types and activate only in diseased cells
- Self-replicating mRNAs for long-acting therapeutic effects
- Bioengineered to control the location, timing, intensity, and duration of protein expression
- Potential for multi-functional and curative treatments